Testing effectiveness (Phase 2)Study completedNCT02738918
What this trial is testing
Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.
Who this might be right for
Renal TransplantAcute Antibody Mediated RejectionMild Immunologic Risk Factor
Assistance Publique - Hôpitaux de Paris 51